PBMs


Book Description

PBMs: Reshaping the Pharmaceutical Distribution Network provides HMOs and other third-party payers with information on the new and increasingly important role of pharmaceutical benefit companies (PBMs) in the health care industry. From this text, you will learn how PBMs can maintain and deliver a quality, cost-effective drug benefit plan to your company while achieving the anticipated market share for the product. PBMs: Reshaping the Pharmaceutical Distribution Network offers you suggestions on how to choose which PBM service is correct for your business, such as what qualifications to look for in a PBM, as well as what questions you should ask a respective company. This text also offers ways on how your company can benefit from becoming a client and may make your business more competitive in the pharmaceutical industry. PBMs: Reshaping the Pharmaceutical Distribution Network also informs you about the controversies that have arisen concerning the new position of PBMs in the industry. Through research and evaluation, this text addresses these issues from many different perspectives and gives you insight into other topics concerning PBMs, including: operating methods that PBMs currently rely on for designing and overseeing a drug benefit plan how the Food and Drug Administration currently views the role of PBMs and why they are contemplating regulatory intervention alerting PBMs, pharmacies, pharmaceutical companies, and managed care organizations to new legal issues involving fraud and abuse affecting pharmacy benefit management and pharmaceutical manufacturers reasons why retail drug chains and pharmacist organizations oppose recent industry developments regarding PBMs whether or not PBMs reflect a move toward greater centralized decisionmaking in the health care systemIn addition, PBMs: Reshaping the Pharmaceutical Distribution Network offers pharmaceutical companies, health care providers, and managed care organizations several suggestions for further research, which may make your business or your business relationships more efficient and productive in the future. If you or your company are considering the services of a pharmacy benefit management, PBMs: Reshaping the Pharmaceutical Distribution Network will guide you in choosing a company that helps you deliver the most cost-effective and efficient pharmaceutical benefits to customers.




Advances in Patient Safety


Book Description

v. 1. Research findings -- v. 2. Concepts and methodology -- v. 3. Implementation issues -- v. 4. Programs, tools and products.







Frequently Prescribed Medications


Book Description

Health Sciences & Professions




Preventing Medication Errors


Book Description

In 1996 the Institute of Medicine launched the Quality Chasm Series, a series of reports focused on assessing and improving the nation's quality of health care. Preventing Medication Errors is the newest volume in the series. Responding to the key messages in earlier volumes of the seriesâ€"To Err Is Human (2000), Crossing the Quality Chasm (2001), and Patient Safety (2004)â€"this book sets forth an agenda for improving the safety of medication use. It begins by providing an overview of the system for drug development, regulation, distribution, and use. Preventing Medication Errors also examines the peer-reviewed literature on the incidence and the cost of medication errors and the effectiveness of error prevention strategies. Presenting data that will foster the reduction of medication errors, the book provides action agendas detailing the measures needed to improve the safety of medication use in both the short- and long-term. Patients, primary health care providers, health care organizations, purchasers of group health care, legislators, and those affiliated with providing medications and medication- related products and services will benefit from this guide to reducing medication errors.




When Painkillers Become Dangerous


Book Description

A timely guide to the misuse and abuse of prescription painkillers that sorts the facts from the fiction for legitimate users and their loved ones. If you are concerned about a loved one's use of pain medications, you need to read this book, When Painkillers Become Dangerous Whether prescribed by a physician as OxyContin or purchased on the street as "hillbilly heroin," painkilling drugs are extremely effective in eliminating physical, emotional, and psychological distress. The problem is that these drugs are also incredibly addictive. Misuse of and addiction to prescription pain medications has become America's latest, complex, and alarming drug abuse trend. In fact, an estimated 2.6 million people currently use prescription pain relievers non-medically-a dangerous practice that could quickly reach epidemic proportions. Best-selling author Drew Pinsky, M.D., and five other leading experts offer practical, plainspoken, and much-needed information about addiction to painkilling drugs. They will help you understand:How addiction to painkilling medication developsWhat to do if a family member is addictedWhat happens in addiction treatmentWhy addiction is a family disease




The Wrong Prescription for Women


Book Description

This groundbreaking book challenges the medicalized approach to women's experiences including menstruation, pregnancy, and menopause and suggests that there are better ways for women to cope with real issues they may face. Before any woman diets, douches, botoxes, reduces, reconstructs, or fills a prescription for antidepressants, statins, hormones, menstrual suppressants, or diet pills, she should read this book. Contesting common medical practice, the book addresses the many aspects of women's lives that have been targeted as "deficient" in order to support the billion-dollar profits of the medical-pharmacological industry and suggests alternatives to these "remedies." The contributors—psychologists, sociologists, and health experts—are also gender experts and feminist scholars who recognize the ways in which gender is an important aspect of the human experience. In this eye-opening work, they challenge the marketing and "science" that increasingly render women's bodies and experiences as a series of symptoms, diseases, and dysfunctions that require treatment by medical professionals who prescribe pharmaceutical and surgical interventions. Each article in the book addresses the marketing of a specific "condition" that has been constructed in a way that convinces a woman that her body is inadequate or her experience and behavior are not good enough. Among the topics addressed are menstruation, menopause, pregnancy, post-partum adjustment, sexual desire, weight, body dissatisfaction, moodiness, depression, grief, and anxiety.




Bottle of Lies


Book Description

A NEW YORK TIMES BESTSELLER * New York Times Notable Book * Best Book of the Year: New York Public Library, Kirkus Reviews, Science Friday With a new postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.




Nursing2022 Drug Handbook


Book Description

THE #1 Drug Guide for nurses & other clinicians...always dependable, always up to date! Look for these outstanding features: Completely updated nursing-focused drug monographs featuring 3,500 generic, brand-name, and combination drugs in an easy A-to-Z format NEW 32 brand-new FDA-approved drugs in this edition, including the COVID-19 drug remdesivir—tabbed and conveniently grouped in a handy “NEW DRUGS” section for easy retrieval NEW Thousands of clinical updates—new dosages and indications, Black Box warnings, genetic-related information, adverse reactions, nursing considerations, clinical alerts, and patient teaching information Special focus on U.S. and Canadian drug safety issues and concerns Photoguide insert with images of 439 commonly prescribed tablets and capsules